Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease

Clinical Neurophysiology

Volumn 122, Issue 5, 2011, Pages 1019-1026

  Marchand Pauvert, V ^a   Gerdelat Mas, A ^b,c   Ory Magne, F ^c   Calvas, F ^d   Mazevet, D ^e   Meunier, S ^f   Brefel Courbon, C ^b,c   Vidailhet, M ^e,f   Simonetta Moreau, M ^b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c CHU PURPAN   (France)

^d Centre Investigation Clinique   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

Deep brain stimulation; L DOPA; Muscle spindle group II afferents; Parkinson; Spinal reflex; Subthalamic nucleus

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELECTROMYOGRAM; FEMALE; FLEXOR MUSCLE; HIGH FREQUENCY STIMULATION; HUMAN; IMPLANTATION; MALE; MUSCLE SPINDLE; NERVE STIMULATION; NEUROLOGIC DISEASE; NEUROMODULATION; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINAL REFLEX; SUBTHALAMIC NUCLEUS; ULNAR NERVE; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; ELECTROMYOGRAPHY; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MUSCLE RIGIDITY; PARKINSON DISEASE; REFLEX;

EID: 79953023527     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.08.015     Document Type: Article

References (48)

1. Anden N.E., Jukes M.G., Lundberg A. The effect of DOPA on the spinal cord. 2. A pharmacological analysis. Acta Physiol Scand 1966, 67:387-397.
2. Andersson G., Sjolund B. The ventral spino-olivocerebellar system in the cat. IV. Spinal transmission after administration of clonidine and L-DOPA. Exp Brain Res 1978, 33:227-240.
3. Berardelli A., Sabra A.F., Hallett M. Physiological mechanisms of rigidity in Parkinson's disease. J Neurol Neurosurg Psychiatry 1983, 46:45-53.
4. Bergmans J., Miller S., Reitsma D.J. Influence of L-DOPA on transmission in long ascending propriospinal pathways in the cat. Brain Res 1973, 62:155-167.
5. Bras H., Cavallari P., Jankowska E. An investigation of local actions of ionophoretically applied DOPA in the spinal cord. Exp Brain Res 1988, 71:447-449.
6. Bras H., Cavallari P., Jankowska E., McCrea D. Comparison of effects of monoamines on transmission in spinal pathways from group I and II muscle afferents in the cat. Exp Brain Res 1989, 76:27-37.
7. Bras H., Jankowska E., Noga B., Skoog B. Comparison of effects of various types of NA and 5-HT agonists on transmission from group II muscle afferents in the cat. Eur J Neurosci 1990, 2:1029-1039.
8. Chen R., Lemon R. Subthalamic nucleus and gait disturbance: interactions between basal ganglia and brainstem and spinal pathways?. Neurology 2004, 63:1150-1151.
9. Cody F.W., MacDermott N., Matthews P.B., Richardson H.C. Observations on the genesis of the stretch reflex in Parkinson's disease. Brain 1986, 109(Pt 2):229-249.
10. Corna S., Grasso M., Nardone A., Schieppati M. Selective depression of medium-latency leg and foot muscle responses to stretch by an alpha 2-agonist in humans. J Physiol 1995, 484(Pt 3):803-809.
11. Delwaide P.J., Pepin J.L., Maertens de Noordhout A. Short-latency autogenic inhibition in patients with Parkinsonian rigidity. Ann Neurol 1991, 30:83-89.
12. Dodge Y. The Oxford dictionary of statistical terms 2003, Oxford University Press.
13. Engberg I., Lundberg A., Ryall R.W. Is the tonic decerebrate inhibition of reflex paths mediated by monoaminergic pathways?. Acta Physiol Scand 1968, 72:123-133.
14. Eriksson J., Olausson B., Jankowska E. Antispastic effects of L-DOPA. Exp Brain Res 1996, 111:296-304.
15. Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale, vol 2; 1987.
16. Florio T., Scarnati E., Confalone G., Minchella D., Galati S., Stanzione P., et al. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat. Eur J Neurosci 2007, 25:1174-1186.
17. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988, 51:745-752.
18. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality, 1967. Neurology 2001, 57:S11-S26.
19. Iglesias C., Marchand-Pauvert V., Lourenco G., Burke D., Pierrot-Deseilligny E. Task-related changes in propriospinal excitation from hand muscles to human flexor carpi radialis motoneurones. J Physiol 2007, 582:1361-1379.
20. Jankowska E., Hammar I., Chojnicka B., Heden C.H. Effects of monoamines on interneurons in four spinal reflex pathways from group I and/or group II muscle afferents. Eur J Neurosci 2000, 12:701-714.
21. Lourenço G., Iglesias C., Cavallari P., Pierrot-Deseilligny E., Marchand-Pauvert V. Mediation of late excitation from human hand muscles via parallel group II spinal and group I transcortical pathways. J Physiol 2006, 572:585-603.
22. Lourenço G., Bleton J.P., Iglesias C., Vidailhet M., Marchand-Pauvert V. Abnormal spinal interactions from hand afferents to forearm muscles in writer's cramp. Clin Neurophysiol 2007, 118:2215-2226.
23. Lourenço G., Iglesias C., Marchand-Pauvert V. Effects produced in human arm and forearm motoneurones after electrical stimulation of ulnar and median nerves at wrist level. Exp Brain Res 2007, 178:267-284.
24. Marchand-Pauvert V., Nicolas G., Pierrot-Deseilligny E. Monosynaptic Ia projections from intrinsic hand muscles to forearm motoneurones in humans. J Physiol 2000, 525(Pt 1):241-252.
25. Marque P., Nicolas G., Simonetta-Moreau M., Pierrot-Deseilligny E., Marchand-Pauvert V. Group II excitations from plantar foot muscles to human leg and thigh motoneurones. Exp Brain Res 2005, 161:486-501.
26. Marsden C.D., Rothwell J.C., Day B.L. Long-latency automatic responses to muscle stretch in man: origin and function. Adv Neurol 1983, 39:509-539.
27. Maruyama W., Naoi M., Narabayashi H. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. J Neurol Sci 1996, 139:141-148.
28. Matthews P.B. Evidence from the use of vibration that the human long-latency stretch reflex depends upon spindle secondary afferents. J Physiol 1984, 348:383-415.
29. Mortimer J.A., Webster D.D. Evidence for a quantitative association between EMG stretch responses and Parkinsonian rigidity. Brain Res 1979, 162:169-173.
30. Nandi D., Jenkinson N., Stein J., Aziz T. The pedunculopontine nucleus in Parkinson's disease: primate studies. Br J Neurosurg 2008, 22(Suppl. 1):S4-S8.
31. Nielsen J., Pierrot-Deseilligny E. Pattern of cutaneous inhibition of the propriospinal-like excitation to human upper limb motoneurones. J Physiol 1991, 434:169-182.
32. Noth J., Schwarz M., Podoll K., Motamedi F. Evidence that low-threshold muscle afferents evoke long-latency stretch reflexes in human hand muscles. J Neurophysiol 1991, 65:1089-1097.
33. Pahapill P.A., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123(Pt 9):1767-1783.
34. Paulus W., Schomburg E.D. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?. Sleep Med Rev 2006, 10:185-196.
35. Pierantozzi M., Palmieri M.G., Galati S., Stanzione P., Peppe A., Tropepi D., et al. Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients. J Neural Transm 2008, 115:731-735.
36. Pierrot-Deseilligny E, Burke, D. The circuitry of the human spinal cord. Its role in motor control and movement disorders; 2005.
37. Potter M., Illert M., Wenzelburger R., Deuschl G., Volkmann J. The effect of subthalamic nucleus stimulation on autogenic inhibition in Parkinson disease. Neurology 2004, 63:1234-1239.
38. Rothwell J.C., Obeso J.A., Traub M.M., Marsden C.D. The behaviour of the long-latency stretch reflex in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1983, 46:35-44.
39. Scatton B., Dennis T., L'Heureux R., Monfort J.C., Duyckaerts C., Javoy-Agid F. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients. Brain Res 1986, 380:181-185.
40. Shink E., Sidibe M., Smith Y. Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus. J Comp Neurol 1997, 382:348-363.
41. Simonetta Moreau M., Meunier S., Vidailhet M., Pol S., Galitzky M., Rascol O. Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's disease. Brain 2002, 125:2125-2133.
42. Skoog B. A comparison of the effects of two antispastic drugs, tizanidine and baclofen, on synaptic transmission from muscle spindle afferents to spinal interneurones in cats. Acta Physiol Scand 1996, 156:81-90.
43. Skoog B., Noga B.R. Dopaminergic control of transmission from group II muscle afferents to spinal neurones in the cat and guinea-pig. Exp Brain Res 1995, 105:39-47.
44. Starke K., Taube H.D., Browski E. Presynaptic receptor systems in catacholamingergic transmission. Biochem Pharmacol 1977, 26:259-268.
45. Takakusaki K., Habaguchi T., Ohtinata-Sugimoto J., Saitoh K., Sakamoto T. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 2003, 119:293-308.
46. Tatton W.G., Bedingham W., Verrier M.C., Blair R.D. Characteristic alterations in responses to imposed wrist displacements in parkinsonian rigidity and dystonia musculorum deformans. Can J Neurol Sci 1984, 11:281-287.
47. Wichmann T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996, 6:751-758.
48. Xia R., Rymer W.Z. The role of shortening reaction in mediating rigidity in Parkinson's disease. Exp Brain Res 2004, 156:524-528.